The molecular characteristics of 480 Mycoplasma pneumoniae polymerase chain reactionpositive specimens (331 were previously reported and 149 were newly reported) collected from pediatric patients in Beijing, China, between 2003 and 2015 were analyzed. Genotype M4-5-7-2/P1 were the most prevalent across the 13-year study period, although the isolation and mutation rates for this genotype varied between the periods
Introduction
Mycoplasma pneumoniae is a common bacterial pathogen that causes upper and lower respiratory tract infections in humans, particularly children and young adults [1] . Worldwide epidemics of M. pneumoniae infection occur every 3-7 years [2] ., and after the last epidemic around 2012, there were significant increases in the number of M. pneumoniae-associated pneumonia cases reported in 2015 in China, Japan, England, and Wales [3, 4, 5] ., there may be another new epidemic started in 2015. Analysis of the molecular characteristics of specimens collected over this period is therefore very important.
The most prevalent M. pneumoniae genotypes, along with drug resistance profiles, can differ between regions and countries [6, 7] ., and even within the same region, type-shifts in predominant P1 genotypes have been recorded in Japan at intervals of about 10 years [8] . However, there is little epidemiological information regarding trends in P1 and multiple locus variable-number tandem repeat analysis (MLVA) genotypes and macrolide resistance mutations in the 23S rRNA gene of M. pneumoniae in China. Therefore, this study aimed to elucidate changes in the molecular characteristics of M. pneumoniae specimens in China over a 13-year period. M. pneumoniae-positive specimens were identified using real-time PCR, as described previously [11] .
P1 gene typing
Nested PCR-restriction fragment-length polymorphism analysis was used for P1 genotyping, and was performed as previously described [9] directly from DNA extracted from the PCRpositive specimens. The PCR products of type 2 specimens were sequenced to identify type 2 variants.
MLVA typing
Multiplex PCR amplification-linked capillary electrophoresis of four loci (Mpn13, Mpn14, Mpn15, and Mpn16) was used for the amended MLVA genotyping, and was performed according to previously described [10] and the international guidelines [12] .
Detection of macrolide resistance
Detection of macrolide resistance mutations, including the common macrolide resistance point mutations at positions 2063, 2064, 2611, and 2617 (M. pneumoniae numbering), was performed as previously described [13] . 
Results and Discussion

P1 gene typing
MLVA typing
Of the 23 specimens collected from 2003-2007, 16 were M. pneumoniae type M4-5-7-2, three were M4-5-7-3, two were M3-5-6-2, and the final two were M3-6-6-2 and M2-5-7-2, respectively. Of the 126 specimens collected from 2014-2015, 109 were M. pneumoniae type M4-5-7-2, 13 were M3-5-6-2, three were M4-5-6-2, and one was M4-5-5-2. When combined with the previously published specimens from 2008-2013, M. pneumoniae DNA corresponding to 12 distinct MLVA types was identified from among the 480 specimens (Table 1 , Fig 1B) . The most common type was M4-5-7-2 (91.0%, 437/480), followed by M3-5 In addition, new MLVA types were observed in every epidemic period. M3-6-6-2 and M4-6-7-2 were first detected in 2003 and 2009, respectively, while M4-4-7-2, M4-5-4-2, M4-5-5-2, M4-6-5-2, M5-5-7-2 and M4-5-6-2 were reported between 2010 and 2015, during and after the last worldwide epidemics [14, 15] . A possible correlation was observed between MLVA locus 13 and P1 typing: 99.8% of M4-5-7-2 specimens (436/437) were P1 type 1, and 100% of M3-5-7-2 (2/2), M3-5-6-2 (18/18), and M3-6-6-2 (1/1) specimens were P1 type 2 or 2c ( Table 2) . As the M. pneumoniae macrolide resistance rates vary from 2.0-13.2% in most European countries and the United States [16] , and are up to 90.0% in China and Japan [15, 17] , this type of antibiotic resistance has become a focus of worldwide research. In this study, the rates of mutation varied throughout the 13-year study period (Fig 1C) . Analysis of data from the three different time periods showed that the resistance mutation rates rose from 87% ( A report by Qu et al. [18] showed a possible association between MLVA type M3-5-6-2 and macrolide susceptibility, and our previous findings [9] showed a possible association between M4-5-7-2 and macrolide resistance. In this study, the macrolide resistance mutations were distributed across 10 distinct MLVA types. Among them, 93.4% were M4-5-7-2 (425/455) and 1.98% were M3-5-6-2 (9/455). Of the 25 specimens with no detectable macrolide resistance mutations, one specimen contained M. pneumoniae DNA that was grouped into genotype M3-6-6-2 (1/25, 4%), one was M4-5-4-2 (1/25, 4%), nine were M3-5-6-2 (9/25, 36%), two were M4-5-6-2 (2/25, 8%), and eight were M4-5-7-2 (8/25, 32%) ( Table 2, Fig 2) . While 50% (9/18) of M3-5-6-2-type specimens had no macrolide resistance mutations, 97.3% (425/437) of M4-5-7-2-type specimens contained resistance mutations ( Table 2, Fig 2) . In addition, rates of resistance mutations increased along with the increase of the M4-5-7-2 type between 2003-2007 and 2008-2013 , and decreased along with the decrease of the M4-5-7-2 type during 2014 and 2015. These findings further indicated that there may be an association between the fourlocus MLVA genotypes and macrolide resistance.
Detection of macrolide resistance mutations
This study examined changes in the molecular characteristics of M. pneumoniae in clinical specimens collected from children in Beijing over a 13-year period. The genotype M4-5-7-2/ P1 was most prevalent in children with M. pneumoniae infection, especially from 2008 to 2013. However, the prevalence of the two main MLVA types, M4-5-7-2 and M3-5-6-2, along with the main P1 gene types, 1 and 2, varied between the three epidemic periods. In particular, some genotypes were only detected in Beijing during and after the last worldwide epidemics. Our study also provides more evidence that there is an association between MLVA type M4-5-7-2 and macrolide resistance.
However, this study also has some limitations. As the number of specimens from 2003-2007 was small, examination of a greater number of specimens will help to better understand the epidemic trends. Moreover, other typing methods, such as pulsed-field gel electrophoresis and multilocus sequence typing, could be used in conjunction with the current methods to enhance the results of further studies [19, 20] . Although a large amount of sequencing is required with multilocus sequence typing, this method has better discriminatory power than MLVA and P1-restriction fragment-length polymorphism analysis. Therefore, more studies using a combination of these methods should be undertaken to investigate associations between clinical infections and specific M. pneumoniae molecular characteristics.
